Collard Craig A (CIK 1363558) reported 14 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-04-21). Recent activity: Buy HRTX (13,797 shares), Buy HRTX (62,500 shares), Buy HRTX (34,789 shares), Buy HRTX (13,797 shares), Buy HRTX (34,789 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-21 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Chief Executive Officer | Buy | 13,797 | $0 |
| 2026-04-06 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Chief Executive Officer | Buy | 62,500 | $0 |
| 2026-02-03 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Chief Executive Officer | Buy | 34,789 | $0 |
| 2026-01-20 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Chief Executive Officer | Buy | 13,797 | $0 |
| 2025-11-04 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Chief Executive Officer | Buy | 34,789 | $0 |
| 2025-10-21 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Chief Executive Officer | Buy | 13,797 | $0 |
| 2025-08-04 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Chief Executive Officer | Buy | 34,789 | $0 |
| 2025-07-22 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Chief Executive Officer | Buy | 13,797 | $0 |
| 2025-06-25 | TerrAscend Corp. (TSNDF) | Director | Buy | 433,653 | $0 |
| 2025-05-02 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Chief Executive Officer | Buy | 34,789 | $0 |
| 2025-04-22 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Chief Executive Officer | Buy | 13,796 | $0 |
| 2025-04-03 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Chief Executive Officer | Buy | 62,500 | $0 |
| 2025-03-26 | TerrAscend Corp. (TSNDF) | Director | Sell | 2,258 | $1,039 |
| 2025-01-22 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Chief Executive Officer | Buy | 13,797 | $0 |
Source: SEC Form 4 filings · as of 2026-04-21